Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

被引：0
|
作者：
Hiroshi Harada
Masakazu Kondo
Akira Maeyama
Takaaki Fukuda
Satoshi Ikemura
Eisuke Shono
Tomomi Tsuru
Yasushi Inoue
Seiji Yoshizawa
Hiroaki Niiro
Yasuharu Nakashima
机构：
[1] Yagi Hospital,Department of Orthopaedic Surgery, Rheumatology Center
[2] Kondo Clinic of Rheumatology and Orthopaedic Surgery,Department of Orthopaedic Surgery
[3] Fukuoka University,Department of Rheumatology
[4] Rheumatology Center,Department of Orthopaedic Surgery
[5] Koga Hospital 21,Department of Rheumatology
[6] Fukuoka Red Cross Hospital,Department of Rheumatology
[7] Shono Rheumatology Clinic,Department of Medicine and Biosystemic Science
[8] Nishijin Prime Building,Department of Orthopaedic Surgery
[9] PS Clinic,undefined
[10] Fukuoka Red Cross Hospital,undefined
[11] Hamanomachi Hospital,undefined
[12] Kyushu University,undefined
[13] Kyushu University,undefined
来源：
Clinical Rheumatology | 2024年 / 43卷
关键词：
Rheumatoid arthritis; Sarilumab; Real-world; Inverse probability of treatment-weighting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1447 / 1459
页数：12
相关论文
共 50 条
  • [31] What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? an Analysis from a Real-World Registry
    Faraawi, Rafat
    Joshi, Raman
    Bensen, William G.
    Choquette, Denis
    Olsynzynski, Wojciech
    Arendse, Regan
    Sheriff, Maqbool
    Rahman, Proton
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Tkaczyk, Cathy
    Osborne, Brendan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    Kim, Tae-Hwan
    Lee, Shin-Seok
    Park, Won
    Song, Yeong Wook
    Suh, Chang-Hee
    Kim, SooKyoung
    Lee, Young Nam
    Yoo, Dae Hyun
    CLINICAL DRUG INVESTIGATION, 2020, 40 (06) : 541 - 553
  • [33] A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    Tae-Hwan Kim
    Shin-Seok Lee
    Won Park
    Yeong Wook Song
    Chang-Hee Suh
    SooKyoung Kim
    Young Nam Lee
    Dae Hyun Yoo
    Clinical Drug Investigation, 2020, 40 : 541 - 553
  • [34] Chemotherapy reduces long-term quality of life in recurrence-free colon cancer survivors (LaTE study)-A nationwide inverse probability of treatment-weighted registry-based cohort study and survey (vol 26, pg 22, 2024)
    Malik, Y. G.
    Benth, J. S.
    Hamre, H. M.
    Faerden, A. E.
    Ignjatovic, D.
    Schultz, J. K.
    COLORECTAL DISEASE, 2024, 26 (06) : 1324 - 1324
  • [35] Effectiveness and Safety of Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: Third Interim Analysis of a German Non-Interventional, Prospective, Multicenter Study (ESCALATE-RA)
    Krueger, Klaus
    Prothmann, Ulrich
    Klopsch, Thilo
    Behmer, Olaf
    Hsieh, Min-Jean
    Jobst, Juergen
    Klaus, Pascal
    Meng, Thomas
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 586 - 589
  • [36] Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Kaneko, Yuko
    Tanaka, Eiichi
    Hirata, Shintaro
    Kurasawa, Takahiko
    Kubo, Satoshi
    Saito, Kazuyoshi
    Shidara, Kumi
    Kimura, Noriko
    Nagasawa, Hayato
    Kameda, Hideto
    Amano, Koichi
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2012, 22 (03) : 327 - 338
  • [37] What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? An Analysis from the Real-world Registry, BioTRAC
    Faraawi, Rafat
    Joshi, Ramen
    Bensen, William
    Choquette, Denis
    Olszynski, Wojciech
    Arendse, Regan
    Sheriff, Maqbool
    Rahman, Proton
    Sampalis, John
    Rampakakis, Emmanouil
    Nantel, Francois
    Lehman, Allen
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1330 - 1330
  • [38] COST-EFFECTIVENESS OF IGURATIMOD IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) BY USING A CLAIMS-BASED ALGORITHM: RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA
    Wang, Y.
    Shi, T.
    Deng, J.
    Wu, J.
    Qu, Y.
    Zhang, Y.
    Zhu, X.
    Liang, B.
    Yu, Q.
    Du, H.
    Jie, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1323 - 1323
  • [39] Inhibitory Effect Of Abatacept On Joint Damage In Rheumatoid Arthritis Patients With Or Without Concomitant Methotrexate: A Retrospective Multicenter Analysis Of 12 Months Of Abatacept Treatment In Routine Clinical Practice
    Nadkarni, A.
    Lobo, F.
    Juday, T.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S619 - S619
  • [40] Being Elderly Is Not a Predictive Factor of Discontinuation of Abatacept Due to Adverse Events in Rheumatoid Arthritis Patients with Concomitant Methotrexate: A Retrospective Observational Study Based on Data from a Japanese Multicenter Registry Study
    Takahashi, Nobunori
    Kojima, Toshihisa
    Asai, Shuji
    Watanabe, Tatsuo
    Matsumoto, Takuya
    Asai, Nobuyuki
    Sobue, Yasumori
    Ishiguro, Naoki
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345